Can you provide the upcoming earnings date for ENVVENO MEDICAL CORP?
ENVVENO MEDICAL CORP (NVNO) will report earnings on 2026-04-28, after the market close.
ENVVENO MEDICAL CORP (NVNO) Forecast, Price Target & Analyst Ratings
NASDAQ:NVNO • US29415J2050
Current stock price
10.51 USD
-1.05 (-9.08%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ENVVENO MEDICAL CORP (NVNO).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Apr 28, 2026
- Period
- Q4 / 2025
- EPS Estimate
- -$0.29
- Revenue Estimate
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of $10.51 to mean target of N/A, Based on 6 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
43.33%
NVNO was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about NVNO.
In the previous month the buy percentage consensus was at a similar level.
NVNO was analyzed by 6 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Apr 28, 2026
- Period
- Q4 / 2025
- EPS Estimate
- -$0.29
- Revenue Estimate
- Revenue Q2Q
- N/A
- EPS Q2Q
- 97.28%
- Number of Analysts
- 3
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%
Next Earnings Summary
NVNO is expected to report earnings on 4/28/2026. The consensus EPS estimate for the next earnings is -0.29 USD and the consensus revenue estimate is 0 USD.
Full Analyst Estimates 2025 - 2028
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 420K -46.84% | 190K -54.76% | 30K -84.21% | -100.00% | 7.14M | 17.136M 140.00% | 29.294M 70.95% | ||||||
| EBITDA YoY % growth | -5.97M -32.37% | -7.4M -23.95% | -6.97M 5.81% | N/A -29.70% | N/A -85.18% | N/A -47.67% | N/A -0.24% | N/A 3.91% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -6.11M -31.12% | -7.53M -23.24% | -7.09M 5.84% | -7.181M -28.91% | -12.842M -84.79% | -25.724M -47.60% | -27.234M -0.28% | -23.735M 4.00% | -24.235M -0.98% | -24.317M -0.34% | -19.523M 19.71% | -12.362M 36.68% | |
| Operating Margin | -1,454.76% | -3,963.16% | -23,633.33% | N/A | N/A | N/A | N/A | N/A | N/A | -340.57% | -113.93% | -42.20% | |
| EPS YoY % growth | N/A | N/A | N/A | -12.14 97.22% | -48.91 -465.17% | -78.90 -11.73% | -73.90 10.50% | -47.12 35.20% | -1.10 97.52% | -1.02 7.41% | -0.75 26.00% | -0.48 36.49% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.29 97.28% | -0.24 96.82% | -0.27 97.70% | -0.27 96.71% | -0.23 17.86% | -0.19 20.83% | -0.20 23.08% | -0.20 23.08% | -0.15 34.78% |
| Revenue Q2Q % growth | 510K | 1.02M | 2.295M | 3.315M | 2.856M 460.00% | 3.672M 260.00% | 4.478M 95.12% | 6.13M 84.92% | |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -6.497M 3.01% | -5.824M -17.57% | -6.406M 9.13% | -6.446M -32.02% | -5.641M 13.19% | -5.08M 12.78% | -5.192M 18.95% | -5.294M 17.88% | -3.958M 29.84% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
25.63%
EPS Next 5 Year
18.76%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
ENVVENO MEDICAL CORP / NVNO Forecast FAQ
What are the consensus estimates for NVNO stock next earnings?
The consensus EPS estimate for the next earnings of ENVVENO MEDICAL CORP (NVNO) is -0.29 USD and the consensus revenue estimate is 0 USD.
What is the number of analysts for NVNO stock?
The number of analysts covering ENVVENO MEDICAL CORP (NVNO) is 6.